GCC Country Report: UAE
Taking a closer look at UAE’s healthcare system, this report provides a snapshot of how... Read More
Beyond Borders: French & English HTA Influence in Saudi Arabia
Rising medicine costs and limited healthcare budgets highlight the need to optimize public resource allocation.... Read More
GCC Country Report: Saudi Arabia
Taking a closer look at Saudi Arabia's healthcare system, this report provides a snapshot of... Read More
Unlocking New Horizons: An Overview of Oncology Therapies in the GCC
The GCC region, marked by accessible markets, adaptable budgets, and a notable oncology burden, offers... Read More
The New Frontier of Growth for Cell & Gene Therapies
With limited access restrictions, flexible budgets and a high burden of genetic diseases, the GCC... Read More
Medical Devices: Pathways to Market and Future Outlook in the Middle East & Africa
Many governments in the Middle East and Africa are actively working to improve healthcare access... Read More
Gearing Towards Successful Pharmaceutical Launch in Oman
We recently conducted an interview with Dr Mahmoud El Shabrawy, the General Manager of a... Read More
Guide to Successful Distributor and Manufacturer Relationships in the GCC
To enter the GCC market, international pharmaceutical and biotech companies are required to either establish... Read More
The Middle East: The Missed Market Opportunity
With a rapid marketing authorization process, the ability to achieve price parity with the US... Read More
The Evolving Biosimilar Policy Landscape in the Middle East
Biosimilar adoption level can vary depending on factors such as the specific healthcare systems, the... Read More
HTA Changes in MENA: What Does the Future Hold for New Product Launches in the Region?
There is growing interest in pharmacoeconomic principles across the Middle East and Africa region. The... Read More
